Presentation SIF 2019 Optimizing a TAVR Program:Assessing Efficacy Plus Excellence From First Contact to Discharge Presenter: Molly Szerlip March 30, 2019
Presentation TCT 2018 MitraClip Patient Selection 2018: Can We Predict An Excellent Result (Sustained MR Less Than or Equal to 1+)? Presenter: Ted Feldman, Joachim Schofer, Karl-Heinz Kuck September 23, 2018
Presentation TCT 2018 First Presentation of the 4-Year EXCEL Outcomes Presenter: Raj Makkar, Patrick W. Serruys, Gregg W. Stone September 23, 2018
Presentation TCT 2018 How Much Has PCI (and CABG) Improved in MVD and LMD: Insights From SYNTAX II and SYNTAX-EXCEL Comparative Analyses Presenter: Antonio Colombo, Jeffrey W. Moses, Patrick W. Serruys September 22, 2018
Presentation TCT 2018 TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener September 22, 2018
Presentation TCT 2018 TCT-106: Are Outcomes Following CABG for Left Main Disease Improving Over the Last Decade? A Propensity-Matched Analysis From the EXCEL and SYNTAX Randomized Trials Presenter: John D. Puskas, Alfredo Trento, Patrick W. Serruys September 21, 2018
Presentation TCT 2018 TCT-105: Non-Periprocedural Myocardial Infarction After CABG in Patients With Left Main Disease: Analysis From the EXCEL Trial Presenter: John D. Puskas, Alfredo Trento, Bjorn Redfors September 21, 2018
Presentation TCT 2018 TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial Presenter: Nicholas J. Lembo, Marie-Claude Morice, R. Jay Widmer September 21, 2018
Presentation TCT 2018 TCT-35: Impact of Cardiovascular Rehospitalizations Following PCI vs CABG for Left Main Coronary Artery Disease: A Sex-Specific Analysis From the EXCEL Trial Presenter: Nicholas J. Lembo, Marie-Claude Morice, Ioanna Kosmidou September 21, 2018
Presentation TCT 2018 TCT-34: Effect of Baseline Anemia on Outcomes After PCI and CABG in Patients With Left Main Disease: The EXCEL Trial Presenter: Nicholas J. Lembo, Marie-Claude Morice, Prakriti Gaba September 21, 2018
Presentation TCT 2018 TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial Presenter: Nicholas J. Lembo, Marie-Claude Morice, Gennaro Giustino September 21, 2018
Presentation TCT 2018 Featured Lecture #2: Democratizing Clinical Excellence: Combining Digitized Patient Data and Guideline-Directed Best Practice Presenter: Sanjeev Bhavnani, Issam D. Moussa, Lonny Reisman September 21, 2018
Presentation The Structural Heart Disease Summit 2018 Perspectives on the Hierarchy of Valve Centers of Excellence in the US Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Brian R Lindman June 21, 2018
Presentation TCT 2017 TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial Presenter: Patrick W. Serruys, Ori Ben-Yehuda November 01, 2017
Presentation TCT 2017 Technical Opportunities Part 2: Telehealth, Cloud-Based Systems, and Centers of Excellence Presenter: G. Burkhard Mackensen, Robert J. Siegel, João L Cavalcante November 01, 2017
Presentation TCT 2017 Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE! Presenter: Sanjay Kaul, Tullio Palmerini, Jacek Legutko November 01, 2017
Presentation TCT 2017 Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE! Presenter: Sanjay Kaul, Tullio Palmerini, Evald H. Christiansen November 01, 2017
Presentation TCT 2017 Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX Presenter: James B. Hermiller Jr., John D. Puskas, Bernard J. Gersh November 01, 2017
Presentation TCT 2017 Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients! Presenter: Evald H. Christiansen, Erick Schampaert, John D. Puskas October 31, 2017
Presentation TCT 2017 Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients! Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein October 31, 2017